EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1

In Vitro Diagnostic Medical Devices Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998

This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.

Last updated 10 rujna 2024. Database contains 4821 unique substances/entries.
Filter the list

M-TMI
402-440-2
2094-99-7
Acute Tox. 2; Skin Corr. 1B; STOT RE 2; Resp. Sens. 1; Skin Sens. 1
244-879-0
22259-30-9
Acute Tox. 2; Skin Sens. 1
245-656-0
23422-53-9
Acute Tox. 2; Skin Sens. 1
209-854-0
594-72-9
Acute Tox. 3
200-629-2
66-71-7
Acute Tox. 3
TRIAZAMATE
411-650-3
110895-43-7
Acute Tox. 3
200-733-8
70-30-4
Acute Tox. 3
-
7076-53-1
Acute Tox. 3
T 1049
403-350-6
17742-69-7
Acute Tox. 3
-
2532-43-6
Acute Tox. 3

Export search results to: